Maduzia D, Matuszyk A, Ceranowicz D, Warzecha Z, Ceranowicz P, Fyderek K, Galazka K, Dembinski A
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland.
Department of Anatomy, Jagiellonian University Medical College, Cracow, Poland.
J Physiol Pharmacol. 2015 Dec;66(6):875-85.
Ghrelin has been primarily shown to exhibit protective and therapeutic effect in the gut. Pretreatment with ghrelin inhibits the development of acute pancreatitis and accelerates pancreatic recovery in the course of this disease. In the stomach, ghrelin reduces gastric mucosal damage induced by ethanol, stress or alendronate, as well as accelerates the healing of acetic acid-induced gastric and duodenal ulcer. The aim of present studies was to investigate the effect of pretreatment with ghrelin on the development of acetic acid-induced colitis. Studies have been performed on male Wistar rats. Animals were treated intraperitoneally with saline (control) or ghrelin (4, 8 or 16 nmol/kg/dose). Saline or ghrelin was given twice: 8 and 1 h before induction of colitis. Colitis was induced by a rectal enema with 1 ml of 4% solution of acetic acid and the severity of colitis was assessed 1 or 24 hours after induction of inflammation. Rectal administration of acetic acid induced colitis in all animals. Damage of colonic wall was seen at the macroscopic and microscopic level. This effect was accompanied by a reduction in colonic blood flow and mucosal DNA synthesis. Moreover, induction of colitis significantly increased mucosal concentration of pro-inflammatory interleukin-1β (IL-1β), activity of myeloperoxidase and concentration of malondialdehyde (MDA). Mucosal activity of superoxide dismutase (SOD) was reduced. Pretreatment with ghrelin reduced the area and grade of mucosal damage. This effect was accompanied by an improvement of blood flow, DNA synthesis and SOD activity in colonic mucosa. Moreover, ghrelin administration reduced mucosal concentration of IL-1β and MDA, as well as decreased mucosal activity of myeloperoxidase. Administration of ghrelin protects the large bowel against the development of the acetic acid-induced colitis and this effect seems to be related to the ghrelin-evoked anti-inflammatory and anti-oxidative effects.
胃饥饿素主要在肠道中表现出保护和治疗作用。胃饥饿素预处理可抑制急性胰腺炎的发展,并在该疾病过程中加速胰腺恢复。在胃中,胃饥饿素可减轻乙醇、应激或阿仑膦酸盐引起的胃黏膜损伤,并加速乙酸诱导的胃和十二指肠溃疡的愈合。本研究的目的是探讨胃饥饿素预处理对乙酸诱导的结肠炎发展的影响。研究选用雄性Wistar大鼠进行。动物腹腔注射生理盐水(对照组)或胃饥饿素(4、8或16 nmol/kg/剂量)。生理盐水或胃饥饿素给药两次:在诱导结肠炎前8小时和1小时。通过直肠灌注1 ml 4%的乙酸溶液诱导结肠炎,并在炎症诱导后1小时或24小时评估结肠炎的严重程度。直肠给予乙酸可在所有动物中诱导结肠炎。在宏观和微观水平均可见结肠壁损伤。这种效应伴随着结肠血流量和黏膜DNA合成的减少。此外,结肠炎的诱导显著增加了促炎白细胞介素-1β(IL-1β)的黏膜浓度、髓过氧化物酶活性和丙二醛(MDA)浓度。超氧化物歧化酶(SOD)的黏膜活性降低。胃饥饿素预处理可减少黏膜损伤的面积和程度。这种效应伴随着结肠黏膜血流量、DNA合成和SOD活性的改善。此外,给予胃饥饿素可降低IL-1β和MDA的黏膜浓度,并降低髓过氧化物酶的黏膜活性。给予胃饥饿素可保护大肠免受乙酸诱导的结肠炎的发展,这种效应似乎与胃饥饿素引起的抗炎和抗氧化作用有关。